Sustained Virologic Response (SVR) in Hepatitis C (HCV) Patients Does Not Demonstrate Differences in Physical Performance, Fatigue, Sleep, and Health-related Quality of Life (HRQL): 410Price, JillianEscheik, CareyAzim, YusufHunt, SharonFang, Yun...
Randomized clinical trials (RCTs) of interventions for the hepatitis C virus have historically used sustained virological response (SVR) at 24 weeks after treatment (SVR24) as the key effect measure. However, recent RCTs investigating the efficacy of new direct acting agents (DAAs) have used SVR...
Recently published data showed a link between sustained virologic response and a reduced risk for hepatocellular carcinoma among patients treated with direct-acting antivirals for hepatitis C. “Data on HCC risk following DAA induced SVR are still sparse and conflicting,”Fasiha Kanw...
Durability of SVR in chronic hepatitis C patients treated with peginterferon-alpha2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther. 2013;38(2):118–23.Mishra A, Younossi Z. Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon-...
For patients in the VX-222 (400mg) arm who received an additional 12 weeks of pegylated-interferon and ribavirin alone, 87 percent (13/15) had undetectable hepatitis C virus 12 weeks after treatment ended. Study results also showed that patients treated with the four-drug regimen experienced ...
Perception of Cure, Health Related Quality of Life and Health Care Utilization in Hepatitis C Patients Who Achieved SVR: 396Miller, TimothyMcBride, RichardJeffries, MarkVincent, JenniferYau, CourtneyOfficial journal of the American College of Gastroenterology | ACG...
Noun1.SVR- Russia's intelligence service responsible for foreign operations, intelligence-gathering and analysis, and the exchange of intelligence information; collaborates with other countries to oppose proliferation of weapons of mass destruction, terrorism and organized crime ...
Original Research SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin Kristian Thorlund, Eric Druyts & Edward J Mills Pages 49-58 | Published online: 15 Jan 2014 Cite this article CrossMark Full Article Figures & data Ref...
Background and study aims We aimed to evaluate the therapeutic efficacy of pegylated interferon alpha-2a 180 μg as a treatment for hepatitis B 'e' anti... Sahar,Maklad,and,... - 《Arab Journal of Gastroenterology》 被引量: 1发表: 2013年 Biological early warning systems for toxicity base...
881 \{HIGH\} \{SVR\} \{RATES\} (SVR4) \{FOR\} 12-WEEK \{TOTAL\} \{TELAPREVIR\} \{COMBINATION\} \{THERAPY\} \{IN\} \{IL28B\} \{CC\} TREATMENT-NAÏVES \{AND\} \{PRIOR\} \{RELAPSERS\} \{WITH\} \{G1\} \{CHRONIC\} \{HEPATITIS\} C: \{CONCISE\} \{INTERIM\} ...